Symposium on steroid hormones. 1. Synthetic progestational steroids. Their significance and use.
article
OA: closed
CC0
AI-generated summary
Synthetic progestational steroids exhibit diverse potencies and actions, with specific compounds showing promise in managing habitual abortion, dysmenorrhea, and endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Synthetic progestational compounds are evaluated in terms of specifi c potencies and actions. The synthetic progestins have a wide spectrum of activity. Certain progestins might be preferred in 1 situation and others elsewhere. In reviewing the progestins, it was concluded that the management of habitual abortion might be most effective by administering 1 gm of progesterone or 40 mg of medroxyprogesterone daily by mouth. As an injectable, 17-hydroxyprogesterone caproate insures constancy of action and promotes a physiologic type of secretory endometrium. Medroxyprogesterone as an oral agent also appears favorable in this regard. The 19-norsteroids appear to have a hemostatic action. They have a definite role in the management of dysmenorrhea. Pregnancy has occurred with astonishing promptness in fertile women who have stopped the use of 19-norsteroids taken previously for contraceptive purposes. The 19-norsteroids and medroxyprogesterone are being used in the treatment of endometriosis. It was concluded that the concept of a synthetic progestin merely as a convenient substitute for progesterone is untenable and does not take advantage of the great potential of these new drugs.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-14T05:59:39.616318+00:00
License: CC0
· commercial use OK